Adapting malaria clinical trials infrastructure to implement COVID-19 epidemiology studies: Response to a public health emergency amid safe continuation of a research enterprise.

Woodford, John; Sagara, Issaka; Dicko, Alassane; Duffy, Patrick E

Woodford, John; Sagara, Issaka; Dicko, Alassane; Duffy, Patrick E.

Woodford J; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States.
Sagara I; Malaria Research and Training Center, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Dicko A; Malaria Research and Training Center, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Duffy PE; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States.

Front Public Health ; 10: 959678, 2022.

Article in English | MEDLINE | ID: covidwho-1993913

Subject(s)

COVID-19; Malaria; COVID-19/epidemiology; COVID-19/prevention & control; Clinical Trials as Topic; Humans; Malaria/epidemiology; Public Health

Keywords

COVID-19; West Africa; malaria; malaria elimination program; pandemic response; public health

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Malaria Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Front Public Health Year: 2022 Document Type: Article Affiliation country: Fpubh.2022.959678

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google